Drugs / Infanrix™-IPV/Hib
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00196976 Background | Mar 2005 → Mar 2006 | meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix-IPV/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00196976 ↗ |
| Known as | DTPa-IPV/Hib vaccine | “DTPa-IPV/Hib vaccine (Infanrix™-IPV/Hib)” NCT00196976 ↗ |
| Modality | Vaccine | “DTPa-IPV/Hib vaccine” NCT00196976 ↗ |
| Route | Intramuscular | “One intramuscular dose during the primary vaccination study” NCT00196976 ↗ |